Education
About Us
Working with TipRanks
Follow Us
Inspire Medical Systems (INSP)
NYSE:INSP
Earnings Data
Report Date
Aug 05, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.21Last Year’s EPS
0.32Same Quarter Last Year
Strong Buy
Based on 15 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 05, 2025
|% Change Since: -1.41%
|Next Earnings Date:Aug 05, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a strong start to the year with significant revenue growth, profitability, and a strategic launch of the new Inspire V system. However, there are some concerns about short-term revenue impacts due to transition challenges and international sales decline. Overall, the long-term outlook remains positive with increased guidance and strategic initiatives in place.Company Guidance
In the first quarter of 2025, Inspire Medical Systems reported impressive financial results, achieving a revenue of $201.3 million, which marks a 23% increase compared to the same period in 2024. Additionally, the company saw a net income of $3 million, translating to $0.1 per diluted share, a significant improvement from the $10 million net loss, or $0.34 per share, experienced in the first quarter of the previous year. Looking forward, Inspire reaffirmed its full-year 2025 revenue guidance, projecting it to be between $940 million and $955 million, which would represent a 17% to 19% growth over the previous year. Furthermore, they adjusted their diluted net income per share guidance upward to a range of $2.2 to $2.3. The company is optimistic about the full launch of its Inspire V system, which is anticipated to drive revenue growth in the latter half of the year. The gross margin for the quarter was stable at 84.7%, and they ended the quarter with a strong cash position of $414 million, despite share repurchases and other investments.Strong Revenue Growth
Revenue for Q1 2025 reached $201.3 million, a 23% increase compared to Q1 2024. U.S. revenue increased by 24% year-over-year.
Profitability Achievement
Net income for Q1 2025 was $3 million, compared to a net loss of $10 million in Q1 2024. This represents a diluted net income of $0.1 per share versus a net loss of $0.34 per share previously.
Inspire V System Full Launch
The Inspire V system will be fully launched in the U.S. this month. It incorporates new technology and capabilities, which have been well received by healthcare providers.
Significant Milestone in Patient Care
Inspire surpassed 100,000 patients receiving therapy since inception, highlighting the significant reach and impact of their treatment.
Increased EPS Guidance
Full year 2025 EPS guidance increased to a range of $2.2 to $2.3 per share, up from prior guidance of $2.1 to $2.2 per share.
---
INSP Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
INSP Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| May 05, 2025 | $158.74 | $161.88 | +1.98% |
| Feb 10, 2025 | $180.99 | $183.99 | +1.66% |
| Nov 04, 2024 | $192.71 | $199.00 | +3.26% |
| Aug 06, 2024 | $147.01 | $188.38 | +28.14% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Inspire Medical Systems (INSP) report earnings?
Inspire Medical Systems (INSP) is schdueled to report earning on Aug 05, 2025, TBA Not Confirmed.
What is Inspire Medical Systems (INSP) earnings time?
Inspire Medical Systems (INSP) earnings time is at Aug 05, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is INSP EPS forecast?
INSP EPS forecast for the fiscal quarter 2025 (Q2) is 0.21.
---